xanomeline and trospium chloride

FDA Drug Profile — Cobenfy

Drug Details

Generic Name
xanomeline and trospium chloride
Brand Names
Cobenfy
Application Number
NDA216158
Sponsor
E.R. Squibb & Sons, L.L.C.
NDC Codes
8
Dosage Forms
KIT, CAPSULE, COATED PELLETS, CAPSULE
Routes
ORAL
Active Ingredients
TROSPIUM CHLORIDE, XANOMELINE, XANOMELINE TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE COBENFY is indicated for the treatment of schizophrenia in adults. COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, indicated for the treatment of schizophrenia in adults. ( 1 )